Correlation Between Arcturus Therapeutics and Equillium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcturus Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcturus Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcturus Therapeutics Holdings and Equillium, you can compare the effects of market volatilities on Arcturus Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcturus Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcturus Therapeutics and Equillium.

Diversification Opportunities for Arcturus Therapeutics and Equillium

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Arcturus and Equillium is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Arcturus Therapeutics Holdings and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Arcturus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcturus Therapeutics Holdings are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Arcturus Therapeutics i.e., Arcturus Therapeutics and Equillium go up and down completely randomly.

Pair Corralation between Arcturus Therapeutics and Equillium

Given the investment horizon of 90 days Arcturus Therapeutics Holdings is expected to generate 1.17 times more return on investment than Equillium. However, Arcturus Therapeutics is 1.17 times more volatile than Equillium. It trades about -0.07 of its potential returns per unit of risk. Equillium is currently generating about -0.16 per unit of risk. If you would invest  1,958  in Arcturus Therapeutics Holdings on September 13, 2024 and sell it today you would lose (210.00) from holding Arcturus Therapeutics Holdings or give up 10.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Arcturus Therapeutics Holdings  vs.  Equillium

 Performance 
       Timeline  
Arcturus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcturus Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Arcturus Therapeutics and Equillium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcturus Therapeutics and Equillium

The main advantage of trading using opposite Arcturus Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcturus Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.
The idea behind Arcturus Therapeutics Holdings and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges